NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-DA-19-029 from the NIH Guide for Grants and Contracts
Notice NOT-DA-19-030 from the NIH Guide for Grants and Contracts
Notice NOT-OD-19-085 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AG-19-030 from the NIH Guide for Grants and Contracts. The Aging Interventions Testing Program (ITP) tests, under standardized conditions, potential intervention strategies which may decelerate the rate of aging in mammals. The rate of aging is to be measured by lifespan extension and/or improvements in health at later ages due to the intervention. The ITP has used lifespan as its primary outcome for an intervention, with limited studies on end-of-life pathologies and selected tests of health across the lifespan (health span). This FOA calls for renewal of the ITP with the following goals: 1) Continue to test compounds for effects on lifespan; 2) Increase histology and pathophysiology analyses at time of death; 3) Increase focused studies of health span on selected compounds.
Funding Opportunity RFA-AG-19-031 from the NIH Guide for Grants and Contracts. The Interventions Testing Program (ITP) tests, under standardized conditions, potential intervention strategies which may decelerate the rate of aging in mammals. The National Institute on Aging (NIA) invites applications specific to establishing a Data Coordinating Center (DCC) that will support storage and analysis of primary and secondary data obtained by the ITP. A public-access website and data repository will be maintained by this DCC to provide access to standard operating procedures and experimental outcomes.
Notice NOT-DA-19-028 from the NIH Guide for Grants and Contracts
Notice NOT-DA-19-027 from the NIH Guide for Grants and Contracts
Notice NOT-DA-19-026 from the NIH Guide for Grants and Contracts
Notice NOT-NR-19-004 from the NIH Guide for Grants and Contracts
Notice NOT-NR-19-005 from the NIH Guide for Grants and Contracts
Notice NOT-NR-19-003 from the NIH Guide for Grants and Contracts
Notice NOT-AI-19-046 from the NIH Guide for Grants and Contracts
Funding Opportunity PA-19-201 from the NIH Guide for Grants and Contracts. The purpose of this FOAs are to encourage mechanistic research to investigate the impact of sleep disturbances on chronic pain. The mechanisms and processes underlying the contribution of sleep disturbances to chronic pain development and maintenance may be very broad. This FOA encourages interdisciplinary collaborations by experts from multiple fieldsneuroscientists, psychologists,endocrinologists, immunologists, geneticists, pharmacologists, chemists, physicists, behavioral scientists, clinicians, caregivers, and others in relevant fields of inquiry.
Funding Opportunity PA-19-200 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to encourage mechanistic research to investigate the impact of sleep disturbances on pain. The mechanisms and processes underlying the contribution of sleep and sleep disturbances to pain perception and the development and maintenance of chronic pain may be very broad. This FOA encourages interdisciplinary research collaborations by experts from multiple fieldsneuroscientists, psychologists, endocrinologists, immunologists, geneticists, pharmacologists, chemists, physicists, behavioral scientists, clinicians, caregivers, and others in relevant fields of inquiry.
Funding Opportunity PAR-19-203 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to establish a joint initiative between the National Eye Institute (NEI) and the Vision Research Program (Vision Research Program) of the Department of Defense (DOD). Through this FOA, the NEI will support meritorious VRP proposals that were unable to be funded by the DOD.
Funding Opportunity PAR-19-204 from the NIH Guide for Grants and Contracts. The Centers of Excellence in Genomic Science (CEGS) program establishes academic Centers for advanced genome research. Each CEGS award supports a multi-investigator, interdisciplinary team to develop transformative genomic approaches to address a biomedical problem. A CEGS project will address a critical issue in genomic science or genomic medicine, proposing a highly innovative solution that would be a major advance. The research will entail substantial risk, balanced by outstanding scientific and management plans and very high potential payoff. A CEGS will focus on the development of novel technological or computational methods for the production or analysis of comprehensive data sets, on a genome-scale biomedical problem, or on other ways to develop and use genomic approaches for understanding biological systems or furthering the application of genomic knowledge, data, and methods towards clinical applications. Each CEGS will nurture genomic science at its institution by facilitating the interaction of investigators from several disciplines. By training new and experienced investigators it will expand the pool of genomics scientists and engineers.
Notice NOT-NR-19-006 from the NIH Guide for Grants and Contracts
Notice NOT-AA-19-011 from the NIH Guide for Grants and Contracts
Notice NOT-AA-19-012 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-MH-20-115 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites innovative research grant applications focused on identifying potential mechanisms and risk factors underlying HIV treatment associated neuropsychiatric symptoms and neurological toxicities experienced by some people living with HIV infection. Exploratory and high-risk research projects that may lead to identification of targets for therapeutic interventions or personalized medicine are appropriate for this FOA. Basic and preclinical research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required.